Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise Forward-looking platform designed to help enable path to new technologies in the electrophysiology (EP) lab Chicago, IL – January 31, 2024 – GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording […]
Tag: EP
Ra Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System
FORT MILL, SC / ACCESSWIRE / July 24, 2023 / Ra Medical Systems, Inc. (NYSE/American:RMED) announced today that there is an increase in clinical adoption by hospitals for its VIVO system. The three-dimensional non-invasive mapping system is one of the product lines within the company’s electrophysiology division, Catheter Precision, LLC. As previously announced, Catheter Precision recently […]
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias
IRVINE, Calif., July 24, 2023 /PRNewswire/ — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small electrodes arranged in a fixed […]
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that its subsidiary BioSig AI Sciences, Inc. (BAIS) was selected to join NVIDIA Inception, a program designed to partner with companies revolutionizing industries with advancements in […]
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) — – BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that […]
Heart Rhythm Society Kicks Off Annual Scientific Sessions In Boston To Unveil Scientific Advances And Innovations In Cardiac Arrhythmia Care
BOSTON, May 8, 2018 /PRNewswire/ — Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing and electrophysiology (EP). The meeting […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center draws cardiac experts from across the globe for EPLive 2018
AUSTIN, Texas, March 19, 2018 /PRNewswire/ — On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia and Latin America, as well as experts from across […]
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Quintain Project Solutions LLC as the manufacturing project management leader for the PURE EP(TM) System. Philadelphia-based […]
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within the emerging electrophysiology (EP) marketplace, announced today that they have made significant progress towards commercialization of their proprietary PURE EP System. The PURE EP System is a […]
The Cath Lab of the Future is Here
JULY 26, 2017 BY Ken Dropiewski (ken@prime-core.com) In March, Miami Cardiac & Vascular Institute announced completion of its state-of-the-art cath lab, with the first next ten image-guided therapy system was being designed to reduce radiation exposure, decrease prep and procedure time and visually eliminate human error in the preparation and treatment of patients being treated for […]